Kevin Kish

3.0k total citations · 1 hit paper
38 papers, 2.0k citations indexed

About

Kevin Kish is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Kevin Kish has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Organic Chemistry and 7 papers in Computational Theory and Mathematics. Recurrent topics in Kevin Kish's work include Melanoma and MAPK Pathways (8 papers), Computational Drug Discovery Methods (6 papers) and Biochemical and Molecular Research (5 papers). Kevin Kish is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Computational Drug Discovery Methods (6 papers) and Biochemical and Molecular Research (5 papers). Kevin Kish collaborates with scholars based in United States, Germany and Italy. Kevin Kish's co-authors include Susan E. Kiefer, Herbert E. Klei, Dianlin Xie, John S. Sack, Yaqun Zhang, John A. Newitt, John S. Tokarski, Michael Wittekind, Janet Cheng and Louis J. Lombardo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Kevin Kish

38 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants

2006 522 citations John S. Tokarski, John A. Newitt et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Kevin Kish	930	433	384	381	305	38	2.0k
Susan E. Kiefer	622 0.7×	404 0.9×	200 0.5×	237 0.6×	226 0.7×	21	1.4k
R.J. Skene	1.4k 1.5×	203 0.5×	455 1.2×	485 1.3×	123 0.4×	34	2.5k
Harshani R. Lawrence	2.1k 2.3×	182 0.4×	272 0.7×	369 1.0×	362 1.2×	75	3.5k
Victor S. Pribluda	1.3k 1.4×	218 0.5×	80 0.2×	154 0.4×	460 1.5×	28	2.8k
Yukimasa Shiotsu	1.1k 1.2×	427 1.0×	78 0.2×	88 0.2×	241 0.8×	47	1.8k
Kathleen Aertgeerts	1.1k 1.2×	255 0.6×	375 1.0×	343 0.9×	58 0.2×	31	2.3k
John S. Tokarski	776 0.8×	419 1.0×	40 0.1×	690 1.8×	63 0.2×	43	2.0k
S. Terzyan	1.1k 1.2×	168 0.4×	94 0.2×	131 0.3×	119 0.4×	53	2.2k
Anne M. Hassell	1.6k 1.7×	184 0.4×	49 0.1×	585 1.5×	107 0.4×	32	2.9k
Edgar R. Wood	1.8k 1.9×	116 0.3×	58 0.2×	694 1.8×	156 0.5×	35	3.7k

Countries citing papers authored by Kevin Kish

Since Specialization

Citations

This map shows the geographic impact of Kevin Kish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kish more than expected).

Fields of papers citing papers by Kevin Kish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Kish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kish. The network helps show where Kevin Kish may publish in the future.

Co-authorship network of co-authors of Kevin Kish

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kish. A scholar is included among the top collaborators of Kevin Kish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kish. Kevin Kish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luo, Guanglin, Ling Chen, Ying Han, et al.. (2023). Structure–activity relationship (SAR) studies on substituted N-(pyridin-3-yl)-2-amino-isonicotinamides as highly potent and selective glycogen synthase kinase-3 (GSK-3) inhibitors. Bioorganic & Medicinal Chemistry Letters. 81. 129143–129143. 9 indexed citations

Hart, Amy C., Lynn M. Abell, Junqing Guo, et al.. (2019). Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage. ACS Medicinal Chemistry Letters. 11(3). 266–271. 31 indexed citations

Sivaprakasam, Prasanna, Xiaojun Han, Rita L. Civiello, et al.. (2015). Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core. Bioorganic & Medicinal Chemistry Letters. 25(9). 1856–1863. 100 indexed citations

Kim, Soong‐Hoon, Keith L. Constantine, Gerald J. Duke, et al.. (2013). Design, synthesis, functional and structural characterization of an inhibitor of N-acetylneuraminate-9-phosphate phosphatase: Observation of extensive dynamics in an enzyme/inhibitor complex. Bioorganic & Medicinal Chemistry Letters. 23(14). 4107–4111. 4 indexed citations

Wrobleski, Stephen T., Shuqun Lin, T. G. Murali Dhar, et al.. (2013). The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode. Bioorganic & Medicinal Chemistry Letters. 23(14). 4120–4126. 15 indexed citations

Kish, Kevin, Patricia A. McDonnell, Valentina Goldfarb, et al.. (2011). Cloning, purification, crystallization and preliminary X-ray analysis of the catalytic domain of human receptor-like protein tyrosine phosphatase γ in three different crystal forms. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 67(7). 768–774. 2 indexed citations

Gentles, Robert G., S. Sheriff, Brett R. Beno, et al.. (2011). Investigation of the mode of binding of a novel series of N-benzyl-4-heteroaryl-1-(phenylsulfonyl)piperazine-2-carboxamides to the hepatitis C virus polymerase. Bioorganic & Medicinal Chemistry Letters. 21(8). 2212–2215. 8 indexed citations

Dyckman, Alaric J., Tianle Li, Sidney Pitt, et al.. (2011). Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(15). 4633–4637. 9 indexed citations

Wang, Wei, Pratik Devasthale, Aiying Wang, et al.. (2011). 7-Oxopyrrolopyridine-derived DPP4 inhibitors—mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site. Bioorganic & Medicinal Chemistry Letters. 21(22). 6646–6651. 15 indexed citations

10.

Lin, Shuqun, Stephen T. Wrobleski, John Hynes, et al.. (2010). Utilization of a nitrogen–sulfur nonbonding interaction in the design of new 2-aminothiazol-5-yl-pyrimidines as p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(19). 5864–5868. 26 indexed citations

11.

Quan, Mimi L., Donald Pinto, Karen A. Rossi, et al.. (2010). Phenyltriazolinones as potent factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(4). 1373–1377. 10 indexed citations

12.

Das, Jagabandhu, Robert V. Moquin, Alaric J. Dyckman, et al.. (2010). 5-Amino-pyrazoles as potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(23). 6886–6889. 19 indexed citations

13.

Shi, Yan, Jing Zhang, Mengxiao Shi, et al.. (2009). Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(15). 4034–4041. 13 indexed citations

14.

Shi, Yan, Chi Li, Stephen P. O’Connor, et al.. (2009). Aroylguanidine-based factor Xa inhibitors: The discovery of BMS-344577. Bioorganic & Medicinal Chemistry Letters. 19(24). 6882–6889. 19 indexed citations

15.

Liu, Chunjian, James C. Lin, Sidney Pitt, et al.. (2008). Benzothiazole based inhibitors of p38α MAP kinase. Bioorganic & Medicinal Chemistry Letters. 18(6). 1874–1879. 47 indexed citations

16.

Wrobleski, Stephen T., Shuqun Lin, John Hynes, et al.. (2008). Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2739–2744. 25 indexed citations

17.

Metzler, William J., Joseph Yanchunas, Carolyn A. Weigelt, et al.. (2008). Involvement of DPP‐IV catalytic residues in enzyme–saxagliptin complex formation. Protein Science. 17(2). 240–250. 103 indexed citations

18.

Das, Jagabandhu, Robert V. Moquin, Sidney Pitt, et al.. (2008). Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2652–2657. 37 indexed citations

19.

Ostrowski, Jacek, John A. Lupisella, Blake C. Beehler, et al.. (2006). Pharmacological and X-Ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats. Endocrinology. 148(1). 4–12. 99 indexed citations

20.

Sulsky, Richard, David R. Magnin, Yanting Huang, et al.. (2006). Potent and selective biphenyl azole inhibitors of adipocyte fatty acid binding protein (aFABP). Bioorganic & Medicinal Chemistry Letters. 17(12). 3511–3515. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact